The deubiquitinase A20 in immunopathology of autoimmune diseases
- PMID: 24673262
- DOI: 10.3109/08916934.2014.900756
The deubiquitinase A20 in immunopathology of autoimmune diseases
Abstract
Deubiquitination-mediated regulation is important for homeostatic NF-κB activation. Aberrant NF-κB activation associated with various inflammatory and autoimmune disorders is linked with defects in the deubiquitinase A20. A20 is an important anti-inflammatory molecule that is induced by multiple signals and has numerous targets. Polymorphisms within the A20 locus or its altered expression are thought to contribute in development of autoimmune disorders. Further various studies in mice models underscore the biological importance of A20 in prevention of inflammatory conditions. Dysregulated A20 is also been suggested as a link between prolonged inflammation and cancer by preliminary reports. This review summarizes the existing understanding and focuses on the new developments in the field of A20 biology. These developments highlight the importance of A20 in pathophysiology of autoimmune disorders and its scope as therapeutics and a biomarker.
Keywords: Deubiquitination; NF-κB; dysregulated A20; inflammation; negative regulation.
Similar articles
-
Regulation of NF-κB signaling by the A20 deubiquitinase.Cell Mol Immunol. 2012 Mar;9(2):123-30. doi: 10.1038/cmi.2011.59. Epub 2012 Feb 20. Cell Mol Immunol. 2012. PMID: 22343828 Free PMC article. Review.
-
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.Trends Immunol. 2009 Aug;30(8):383-91. doi: 10.1016/j.it.2009.05.007. Epub 2009 Jul 28. Trends Immunol. 2009. PMID: 19643665 Review.
-
Expression, biological activities and mechanisms of action of A20 (TNFAIP3).Biochem Pharmacol. 2010 Dec 15;80(12):2009-20. doi: 10.1016/j.bcp.2010.06.044. Epub 2010 Jul 3. Biochem Pharmacol. 2010. PMID: 20599425 Review.
-
The deubiquitinase activity of A20 is dispensable for NF-κB signaling.EMBO Rep. 2014 Jul;15(7):775-83. doi: 10.15252/embr.201338305. Epub 2014 May 30. EMBO Rep. 2014. PMID: 24878851 Free PMC article.
-
[Immune regulation role of A20 and its clinical significance].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Aug;19(4):851-6. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 21867600 Chinese.
Cited by
-
A20 Ameliorates Intracerebral Hemorrhage-Induced Inflammatory Injury by Regulating TRAF6 Polyubiquitination.J Immunol. 2017 Jan 15;198(2):820-831. doi: 10.4049/jimmunol.1600334. Epub 2016 Dec 16. J Immunol. 2017. PMID: 27986908 Free PMC article.
-
Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.Immunol Rev. 2016 Jan;269(1):212-27. doi: 10.1111/imr.12381. Immunol Rev. 2016. PMID: 26683155 Free PMC article. Review.
-
A20 in Kidney Transplantation and Autoimmunity.Int J Mol Sci. 2024 Jun 16;25(12):6628. doi: 10.3390/ijms25126628. Int J Mol Sci. 2024. PMID: 38928333 Free PMC article. Review.
-
Alterations and abnormal expression of A20 in peripheral monocyte subtypes in patients with rheumatoid arthritis.Clin Rheumatol. 2021 Jan;40(1):341-348. doi: 10.1007/s10067-020-05137-w. Epub 2020 Jun 2. Clin Rheumatol. 2021. PMID: 32488768
-
A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?Neurotox Res. 2017 Jul;32(1):1-7. doi: 10.1007/s12640-017-9724-y. Epub 2017 Mar 23. Neurotox Res. 2017. PMID: 28337659
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
